Generate a tailored SOP for Dr. Michael Shelanski. Improve your application with a focused, well-structured draft.
Michael L. Shelanski is a prominent figure in the field of Alzheimer's disease and aging research, holding the position of Henry Taub Professor at Columbia University. His laboratory focuses on understanding the mechanisms behind memory disruption and synaptic dysfunction associated with Alzheimer's disease, utilizing a range of methodologies including cell culture and transgenic animal models. Shelanski's research has significantly contributed to the understanding of the role of amyloid precursor protein (APP) and its derivatives in neuronal cell activity, dendritic spine morphology, and behavior. His work also explores the PKA-CREB signaling pathway and the effects of A-beta on neuronal function and neurogenesis. He has served on various committees, including the Neurology Study Section for the National Institutes of Health and has received numerous honors, showcasing his impact on neurology and biomedicine.
Columbia University • New York, NY
Overseeing research initiatives focused on Alzheimer's disease at Columbia University.
Taub Institute for Research on Alzheimer's Disease and the Aging Brain • New York, NY
Leading research efforts and collaborations in the field of Alzheimer's disease.
Department of Anthropology (GSAS)